Cardiovascular diseases have emerged as a significant health burden and became a leading cause of mortality in developing countries like India.In cardiovascular diseases, acute coronary syndromes are the primary cause of morbidity and mortality, for which timely diagnosis and appropriate therapy are of foremost importance to improve clinical outcomes.Different scoring systems are now available based on initial clinical history, electrocardiographic and laboratory tests that enable early risk stratification on admission. The risk scores were created and recommended by national and international guidelines to identify patients with a higher probability of adverse events, recommending more intensive treatment and early angiography in this population.In this study, we considered evaluating clinical predictors and suitable risk scores GRACE and TIMI that correlate with the severity of angiographic extent of coronary artery disease in patients presenting with ST-elevation myocardial infarction using Modified GENSINI score.
Vascular anomalies are present in the posterior circulation. In the case of this stroke patient, the posterior cerebral artery (PCA) was shown to have a fetal origin. A fetal PCA is classified as either a partial or complete fetal PCA, which can be determined by the presence of a remnant or absence of P1, the PCA segment directly arising from the terminal of the basilar artery. If absent, the PCA has arisen completely from the internal carotid artery (ICA) and is termed complete fetal PCA, or cfPCA. A partial fetal PCA, or pfPCA, is what is found when a hypoplastic segment persists. Here, we report a partial infarction of the oculomotor nucleus with ipsilateral fetal PCA in a 59-year-old female.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.